The associations between FAT4 expression and various clinicopathological features (stage, race, sex, age, weight, grade, nodal metastasis, TP53 mutation status, and tumor histology) of HCC were also determined using the UALCAN database. This evidence concerns the gene FAT4 and hepatocellular carcinoma.